http://www.advfn.com/nasdaq/rss.asp?symbol=ZGEN Zymogenetics Company Newsfeed en Wed, 29 Sep 2010 07:03:38 EDT Wed, 29 Sep 2010 07:03:38 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44574374&headline=zymogenetics-reports-positive-results-in-melanoma-study http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44574374&headline=zymogenetics-reports-positive-results-in-melanoma-study <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> ZymoGenetics Inc. (ZGEN) said an experimental immunotherapy treatment for metastatic melanoma showed "positive survival" results in a mid-stage trial. </p> <p> The data come in the midst of Bristol-Myers Squibb Co.'s (BMY) $836 million buyout... Wed, 29 Sep 2010 07:03:38 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44279448&headline=novo-nordisk-agrees-to-sell-zymogenetics-stake-for-dkk1-1-billion http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44279448&headline=novo-nordisk-agrees-to-sell-zymogenetics-stake-for-dkk1-1-billion <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Danish pharmaceutical company Novo Nordisk A/S (NVO) said Wednesday it will receive 1.1 billion Danish kroner ($187.7 million) after agreeing to sell its 26% stake in biopharmaceutical firm ZymoGenetics Inc. (ZGEN) to Bristol-Myers Squibb Co. (BMY... Wed, 08 Sep 2010 02:00:11 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44278729&headline=bristol-myers-squibb-to-buy-biotech-zymogenetics-for-836-million http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=44278729&headline=bristol-myers-squibb-to-buy-biotech-zymogenetics-for-836-million <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Bristol-Myers Squibb Co. (BMY) has agreed to pay $9.75 a share in cash for biotechnology company ZymoGenetics Inc. (ZGEN), an 84% premium from the closing price Tuesday. </p> <p> ZymoGenetics's shares shot up 83% to $9.70 after hours. The stock... Tue, 07 Sep 2010 18:39:13 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=40673460&headline=novo-nordisk-signs-license-and-patent-deal-with-zymogenetics http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZGEN&article=40673460&headline=novo-nordisk-signs-license-and-patent-deal-with-zymogenetics <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Novo Nordisk said Tuesday it has signed a deal with ZymoGenetics where it will in-license a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and... Tue, 08 Dec 2009 02:39:00 EST